Literature DB >> 32209384

Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources.

Zuqin Zhang1, Wei Yao1, Yan Wang1, Cheng Long2, Xinmiao Fu3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32209384      PMCID: PMC7163181          DOI: 10.1016/j.jinf.2020.03.018

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
The 2019 novel coronavirus diseases (COVID-19) outbreak caused by SARS-CoV-2 is on-going in China and has hit many countries.1, 2, 3 As of 3 March 2020, there have been 80,270 confirmed cases and 2981 deaths in China, most of which are from the epicenter of the outbreak, Wuhan City, the capital of Hubei Province. New COVID-19 cases have been steadily declining in China and more than 60,000 patients have been recovered, largely due to the effective implementation of comprehensive control measures in China. , Here we report that some of these measures, such as a dramatic and timely increase of medical supplies, may play a critical role such that the mortality and recovery rates of COVID-19 in Wuhan follow exponential decay and growth modes, respectively. We collected data for analysis on the officially released cumulative numbers of confirmed, dead and recovered cases (from 23 Jan to 3 Mar 2020) in five geographic regions, i.e., mainland China, Hubei Province, outside Hubei (in China), Wuhan City and outside Wuhan (in Hubei). As of 3 Mar 2020, crude fatality ratios (CFRs) in the above regions are 0.027±0.006, 0.035±0.007, 0.005±0.002, 0.045±0.012 and 0.021±0.008, respectively, in line with earlier reports. , While the mortality rates of COVID-19 outside Hubei and outside Wuhan appear constant over time, the mortality rates in Hubei and Wuhan decline continuously (Fig. 1 (A)). Strikingly, the mortality rates in Hubei and Wuhan are well-fitted with the exponential decay mode (R being 0.93 and 0.82, respectively; Fig. 1(A) and Table S1), and it is the same forth with that in China (R being 0.86) but not with that outside Hubei and outside Wuhan (R being 0.39 and 0.32, respectively). Remarkably, we found that the recovery rates of COVID-19 patients in the above regions were all well-fitted with the exponential growth mode (R being 0.96, 0.95, 0.95, 0.88 and 0.95, respectively; Fig. 1(B) and Table S1). Such intriguing pattern for the COVID-19 mortality and recovery rates in Wuhan (or Hubei) somehow contradicts traditional epidemiological models wherein both are assumed as constants.
Fig. 1

Fitting the COVID-19 mortality and recovery rates with exponential decay and growth functions, respectively and timely supply of medical resources. (A, B) Mortality rate (panel A) and recovery rate (panel B) for COVID-19 in China over time and by location, with exponential decay- and growth-based regression analyses being performed, respectively (as shown by colored solid lines). Parameters from the regression analyses are shown in Table S1, with R being shown here. (C) Numbers of the aided health workers in Hubei over time. Ratio of the aided health workers to patients was also plotted (note: most of the aided health workers are working in Wuhan; refer to Table S3). (D) Numbers of the remaining confirmed cases of COVID-19, and acute care beds, makeshift beds from Fangcang hospitals and total beds in Wuhan over time. Ratio of beds to patients was also plotted. Here the data of newly supplied beds in Hubei are not available and thus the data for Wuhan were analyzed.

Fitting the COVID-19 mortality and recovery rates with exponential decay and growth functions, respectively and timely supply of medical resources. (A, B) Mortality rate (panel A) and recovery rate (panel B) for COVID-19 in China over time and by location, with exponential decay- and growth-based regression analyses being performed, respectively (as shown by colored solid lines). Parameters from the regression analyses are shown in Table S1, with R being shown here. (C) Numbers of the aided health workers in Hubei over time. Ratio of the aided health workers to patients was also plotted (note: most of the aided health workers are working in Wuhan; refer to Table S3). (D) Numbers of the remaining confirmed cases of COVID-19, and acute care beds, makeshift beds from Fangcang hospitals and total beds in Wuhan over time. Ratio of beds to patients was also plotted. Here the data of newly supplied beds in Hubei are not available and thus the data for Wuhan were analyzed. The above unique pattern may reflect the fact that COVID-19 patients in Wuhan (or Hubei) have been treated more effectively day by day. Here we focused on two components essential for effective treatments, i.e., the supply of health workers and hospital beds. As a matter of fact, a great number (up to 42,000, as of 1 March 2020) of health workers have been aided by other provinces in China (Table S2) and they are working in different cities of Hubei (Table S3). This extraordinary aid keeps the ratio of the health workers to patients in Hubei at above 0.6 despite the number of remaining confirmed cases has ten-fold increased up to 50,000 on 18 Feb (Fig. 1(C)). Results also show that the number of acute care beds from more than 45 designated hospitals plus two newly built ones in Wuhan has been consecutively increasing up to 23,532 (as of Feb 24) under the government-directed re-allocation (Fig. 1(D)). This supply thus enabled the severe and critical patients to be treated timely and effectively. More importantly, there have been over 10 temporary hospitals (named Fangcang hospitals) reconstructed from gymnasium and exhibition centers, which provide more than 26 000 makeshift beds for mild patients (Fig. 1(D)). These combinations guaranteed nearly 100% of COVID-19 patients to be treated in hospitals even if the number of remaining confirmed cases has ten-fold increased up to 38 000 on 18 Feb (Fig. 1(D)). In contrast, a lot of patients had to stay at home in the early stage of the outbreak in Wuhan due to the shortage of beds such that many transmissions in households occurred. Accordingly, the effective implementation of comprehensive control measures and infection-treatment practices is critical for combatting any new pathogens, not only interrupting the transmissions but also saving the patients. Timely supplied medical resources, including re-allocation of acute care beds, rapid construction of new hospitals and generous aid of health workers by other less-severe areas, apparently help the epicenter of the outbreak Hubei (Wuhan) to accomplish a unique and also encouraging outcome for life-saving such that the mortality and recovery rates of nearly 50,000 COVID-19 patients exponentially decays and grows, respectively. Other crucial factors contributing to this success may include the improved and optimized diagnosis and treatment strategies, which are critical for saving severe and critical patients. , , This speculation appears to be supported by the exponential growth of the COVID-19 recovery rate outside Hubei (Fig. 1(B)) where medical resources are relatively sufficient over time. Collectively, the achievement made in Hubei (or Wuhan) may provide useful guidance for many countries to be better prepared for the potential pandemic that may overwhelm local health care systems.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  1 in total

1.  Richards model revisited: validation by and application to infection dynamics.

Authors:  Xiang-Sheng Wang; Jianhong Wu; Yong Yang
Journal:  J Theor Biol       Date:  2012-08-07       Impact factor: 2.691

  1 in total
  33 in total

1.  Changes Adopted in Asian Pediatric Hospitals during the COVID-19 Pandemic: A Report from the Pediatric Acute and Critical Care COVID-19 Registry of Asia.

Authors:  Judith J M Wong; Qalab Abbas; Nattachai Anantasit; Naoki Shimizu; Ririe F Malisie; Hongxing Dang; Feng Xu; Jacqueline S M Ong; Pei Chuen Lee; Osamu Saito; Kah Min Pon; Takanari Ikeyama; Muralidharan Jayashree; Rujipat Samransamruajkit; Yibing Cheng; Felix Liauw; Hiroshi Kurosawa; Audrey A N Diaz; Chin Seng Gan; Furong Zhang; Jan Hau Lee
Journal:  J Pediatr Intensive Care       Date:  2021-01-19

2.  Examining the impact of COVID-19 vaccination rates on differential access to critical care.

Authors:  Gordon Cromley; Jie Lin
Journal:  Appl Geogr       Date:  2022-06-21

3.  Development of Machine-Learning Model to Predict COVID-19 Mortality: Application of Ensemble Model and Regarding Feature Impacts.

Authors:  Seung-Min Baik; Miae Lee; Kyung-Sook Hong; Dong-Jin Park
Journal:  Diagnostics (Basel)       Date:  2022-06-14

4.  A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic.

Authors:  Hyung-Jun Kim; Hyeontaek Hwang; Hyunsook Hong; Jae-Joon Yim; Jinwoo Lee
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

5.  Factors associated with anxiety and quality of life of the Wuhan populace during the COVID-19 pandemic.

Authors:  Cheng Liu; Ya-Chen Lee; Ying-Lien Lin; Shang-Yu Yang
Journal:  Stress Health       Date:  2021-04-01       Impact factor: 3.454

6.  Frequency of Abnormalities Detected by Point-of-Care Lung Ultrasound in Symptomatic COVID-19 Patients: Systematic Review and Meta-Analysis.

Authors:  Mouhand F H Mohamed; Shaikha Al-Shokri; Zohaib Yousaf; Mohammed Danjuma; Jessiya Parambil; Samreen Mohamed; Mahmood Mubasher; Mujahed M Dauleh; Bara Hasanain; Mohamed Awni AlKahlout; Ibrahim Y Abubeker
Journal:  Am J Trop Med Hyg       Date:  2020-06-02       Impact factor: 2.345

7.  Coronavirus disease 2019-The principles of the curve, explained simply.

Authors:  Yelda Jozaghi
Journal:  Head Neck       Date:  2020-06-01       Impact factor: 3.147

8.  On the management of COVID-19 pandemic in Italy.

Authors:  Fabio Gaetano Santeramo; Marco Tappi; Emilia Lamonaca
Journal:  Health Policy       Date:  2021-05-31       Impact factor: 2.980

9.  Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study.

Authors:  Allan B Massie; Brian J Boyarsky; William A Werbel; Sunjae Bae; Eric K H Chow; Robin K Avery; Christine M Durand; Niraj Desai; Daniel Brennan; Jacqueline M Garonzik-Wang; Dorry L Segev
Journal:  Am J Transplant       Date:  2020-07-15       Impact factor: 9.369

Review 10.  The COVID-19 pandemic, personal protective equipment and respirator: A narrative review.

Authors:  Jennifer F Ha
Journal:  Int J Clin Pract       Date:  2020-06-28       Impact factor: 3.149

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.